• Herbiron in accordance with the concept of Chinese and Western cultures, is composed of Chinese herbal medicine and well-known study Ferrous Bisglycinate.
  • Ferrous Bisglycinate is easily absorbed by the body, can increase iron utilization, more than other iron supplements.
  • Herbiron was approved as the new drug by Ministry of Health and Welfare (MOHW) in 2013.
  • Herbiron’s clinical efficacy was confirmed in Phase III trials to significantly improve symptoms of iron deficiency anemia in women before menopause and relieved Dysmenorrhea.
  • The safety of Herbiron was demonstrated in Phase III trials, and the incidence of gastrointestinal side effects was significantly reduced in Herbiron-treated subjects compared to subjects treated with ferrous sulfate.